Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. (Q53203057)
Jump to navigation
Jump to search
scientific article published in January 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. |
scientific article published in January 1995 |
Statements
Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone (English)
Harr SD
Simonian NA
1 January 1995